Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

2013 ACR/ARHP Annual Meeting: Strides Made in Understanding Systemic Sclerosis

Susan Bernstein  |  February 1, 2014

Greater knowledge of how vasculitis, fibrosis, and autoimmunity interact in these destructive diseases will result in better clinical management

2013 ACR/ARHP Annual Meeting: Inflammatory Eye Disease Management Can Benefit from Collaboration between Rheumatologists and Ophthalmologists

Susan Bernstein  |  February 1, 2014

Joint effort is critical to diagnosing and treating uveitis, iritis, and other autoimmune eye disorders in patients with inflammatory disease

2013 ACR/ARHP Annual Meeting: Clues to Predictors of Autoimmune Disease Revealed

Susan Bernstein  |  February 1, 2014

New research clarifies signs of rheumatoid arthritis and systemic lupus erythematosus years in advance and could lead to presymptomatic treatment intervention

2013 ACR/ARHP Annual Meeting: Research Provides Insight into Preclinical Rheumatic Disease

Mary Beth Nierengarten  |  February 1, 2014

Data offer clues to role of mucosal biology in etiology of rheumatoid arthrits and early pathology of rheumatic diseases

2013 ACR/ARHP Annual Meeting: Diagnostic,Treatment Approaches Evolve for Kawasaki Disease

Mary Beth Nierengarten  |  February 1, 2014

New data examine infliximab as a treatment option, and updated diagnostic criteria aids physicians in recognizing KD and detecting cardiac involvement in patients

Pharmacy-based Arthritis Screening Debuts in Canada

Kurt Ullman  |  February 1, 2014

Co-sponsored program between the Ministry of Health and pharmacy chain tasks pharmacists with screening people for knee osteoarthritis

Letters: More Tools for Inflammatory Myopathies

Stephan Regenass, MD  |  February 1, 2014

A reader offers more diagnostic tools for inflammatory myopathies

Letters: A Word of Caution on Colchicine Study

Gurjit S. Kaeley, MRCP  |  February 1, 2014

A rheumatologist warns against generalizing findings of the study reported in “Colchine Effective for Acute Pericarditis” [published online October 31, 2013] to all patients with rheumatic diseases

Practice Page: Is In-house or Outsourced Medical Billing Right for Your Physician Practice?

Staff  |  February 1, 2014

What to consider when deciding whether to delegate claims billing in-house or to contract with an outside company

Coding Corner Answer: February Coding Challenge

Staff  |  February 1, 2014

Coding for an office visit by a patient with rheumatoid arthritis and osteoporosis who is evaluated before starting a tumor necrosis factor inhibitor

  • « Previous Page
  • 1
  • …
  • 632
  • 633
  • 634
  • 635
  • 636
  • …
  • 816
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences